Low cost osteoporosis drugs are strictly rationed for the under 75s, and UK physicians hampered by restrictive guidelines, according to findings which appear in the journal Therapeutic Advances in Musculoskeletal Disease, published by SAGE. A leading Cambridge University bone health expert has outlined flaws in NICE osteoporosis treatment guidance, which limits options for many postmenopausal women in the under-75 age bracket. According to Cambridge University Professor of Bone Medicine, Juliet Compston, the current UK guidelines are unnecessarily complex…

Read the original here: 
NICE Guidelines Ration Affordable Osteoporosis Drugs

Related posts:

1. Skull Bone’s Resistance To Osteoporosis Opens Way For New Treatment, PreventionUK scientists curious to discover why unlike the weight-bearing bone in our limbs, skull bone does not get thin as it ages, even in post-menopausal women, have found some quite...
2. Osteoporosis: Types, Symptoms, And Risk FactorsWith the graying of America, more patients will enter our offices with osteoporosis. Fortunately, most will have only a relative contraindication to manipulation, giving us many options for relieving symptoms....
3. Link Between Depression And OsteoporosisResearch carried out among thousands of people has shown a clear connection between depression and a loss of bone mass, leading to osteoporosis and fractures. This was revealed by Hebrew...
4. Judgement In Favour Of NICE On Judicial Review Of Abatacept For Rheumatoid Arthritis GuidanceThe High Court has ruled in favour of NICE by dismissing the application from Bristol Myers Squibb (BMS), the manufacturer of abatacept, for a judicial review of the NICE guidance...
5. NICE Draft Guidance Recommends New Treatment Option For Advanced Soft Tissue SarcomaA new treatment which could extend the lives of a specific group of cancer patients will be available on the NHS. In the final draft of guidance published today (21...
6. New Survey Shows Gap In Diagnosis And Treatment Of Osteoporosis Among Post-Menopausal Women Studied Who Were Hospitalized With FracturesNew results from a survey of 1,122 post-menopausal women in Asia found that nearly half (48.5 percent) were not aware whether or not they had osteoporosis despite being hospitalized with...
7. Zosano Pharma, Inc. Announces Publication Of Positive Phase 2 Study Of Its ZP-PTH Patch For Osteoporosis TherapyZosano Pharma, Inc., a privately held pharmaceutical company developing products using a novel transdermal delivery technology, announced publication in the current issue of the Journal of Clinical Endocrinology and Metabolism...
8. NICE To Publish Final Guidance On Topotecan For The Treatment Of Small-cell Lung Cancer And Preliminary Recommendations For BevacizumabNICE will be making two announcements on cancer treatments this week. ...
9. Mutation In A MiroRNA: New Cause Of OsteoporosisMany biological processes are controlled by small molecules known as microRNAs, which work by suppressing the expression of specific sets of genes. Xiang-Hang Luo and colleagues, at Second Xiangya Hospital...
10. Preventing Osteoporosis and Hip FracturesMy friend Brandy Cunningham was recently in the hospital because of a broken hip. She had been hiking in Bryce Canyon National Park and took a tumble. It was quite...
11. Annals Of Internal Medicine Publishes New USPSTF Breast Cancer Screening GuidelinesIn an update to its 2002 recommendations, the U.S. Preventive Services Task Force (USPSTF) now recommends against routine breast cancer screening for women under the age of 50. Women between...
12. NICE Appraisal Of Sorafenib For Advanced Hepatocellular CarcinomaThe National Institute for Health and Clinical Excellence (NICE) is currently appraising the use of sorafenib for advanced hepatocellular carcinoma (HCC) in patients for whom surgery or therapies in the...
13. WHO Revises Clinical H1N1 Guidelines, Sends Antivirals To Some Hard-Hit NationsOn Thursday, the WHO issued revised guidance for the clinical management of H1N1 (swine) flu, the Associated Press reports. According to the AP, the WHO "says doctors shouldn't wait for...
14. Improved Cancer Screening Becomes Crucial As Debate Swirls Over Guidelines For Breast And Cervical TestsTwo sets of recommendations issued earlier this month have revised longstanding guidelines concerning the age at which women should first be tested for breast and cervical cancer and how frequently....
15. FDA Takes Further Steps To Set Clear Guidelines For PET RadiopharmaceuticalsThe U.S. Food and Drug Administration (FDA) announced publication of a final regulation on current good manufacturing practices (cGMPs) for the production of positron emission tomography (PET) drugs, as well...